Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28085068)
Watch
English
Time for a change: addressing R&D and commercialization challenges for antibacterials
scientific article published on 5 June 2015
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
1 reference
stated in
Europe PubMed Central
title
Time for a change: addressing R&D and commercialization challenges for antibacterials
(English)
1 reference
stated in
PubMed
main subject
commercialization
1 reference
based on heuristic
inferred from title
author name string
D. J. Payne
series ordinal
1
1 reference
stated in
Crossref
L. F. Miller
series ordinal
2
1 reference
stated in
Crossref
D. Findlay
series ordinal
3
1 reference
stated in
Crossref
J. Anderson
series ordinal
4
1 reference
stated in
Crossref
L. Marks
series ordinal
5
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
5 June 2015
1 reference
stated in
PubMed
published in
Philosophical Transactions of the Royal Society B
1 reference
stated in
PubMed
volume
370
1 reference
stated in
PubMed
issue
1670
1 reference
stated in
PubMed
page(s)
20140086
1 reference
stated in
PubMed
cites work
Type IIA topoisomerase inhibition by a new class of antibacterial agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
20 March 2017
How to improve R&D productivity: the pharmaceutical industry's grand challenge
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
20 March 2017
Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
20 March 2017
Drugs for bad bugs: confronting the challenges of antibacterial discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
7 April 2017
Cancer immunotherapy comes of age
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
7 April 2017
Clostridium difficile infection in the twenty-first century
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
29 September 2017
Better tests, better care: improved diagnostics for infectious diseases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
29 September 2017
Improvement of the pharmacokinetics and in vivo antibacterial efficacy of a novel type IIa topoisomerase inhibitor by formulation in liposomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
29 September 2017
Siderophore conjugates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
29 September 2017
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
29 September 2017
Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
29 September 2017
Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424435
retrieved
2 June 2018
TRANSLOCATION project: how to get good drugs into bad bugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1098%2FRSTB.2014.0086
retrieved
21 January 2018
Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1098%2FRSTB.2014.0086
retrieved
21 January 2018
Identifiers
DOI
10.1098/RSTB.2014.0086
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1765545
OpenCitations bibliographic resource ID
1765545
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1765545
PMC publication ID
4424435
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1765545
PubMed publication ID
25918443
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1765545
ResearchGate publication ID
275586317
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
